Inflammatory Disorders

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA safety_alert · 2022-11-11
EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
The EMA confirms risk-minimising measures for Janus kinase inhibitors used in chronic inflammatory disorders to address serious side effects…